Triducive

Triducive

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Triducive operates as a specialized service provider in the evidence generation and medical affairs space, leveraging formal consensus techniques like the Delphi Method. The company designs and facilitates expert panels for pharmaceutical, medical device, and medical society clients, turning panel outcomes into published evidence and targeted communication campaigns. With over 50 published Delphi studies, Triducive helps clients address evidence gaps, define best practices, and build advocacy to support product launches and healthcare policy changes. It is a private, services-oriented business with a global client base.

Infectious DiseaseCardiologyNephrologyHeart FailureChronic Kidney DiseaseSurgery

Technology Platform

Proprietary methodology and operational expertise in structured consensus techniques, primarily the Delphi Method. This includes expert panel recruitment/management, iterative questionnaire design with controlled feedback, consensus thresholding analysis, and a publication/dissemination engine.

Opportunities

Growing demand from pharma/medtech for post-trial evidence to support market access and appropriate use of new therapies.
Expansion of services to more medical societies for clinical guideline development.
Potential to integrate AI tools to enhance panel analysis or identify evidence gaps.

Risk Factors

Revenue dependency on cyclical client R&D/medical affairs budgets.
Reputational risk if methodological rigor of consensus studies is questioned.
Competition from other consultancies or internal client teams developing similar capabilities.

Competitive Landscape

Competes with broad medical affairs consultancies and evidence generation CROs that may offer consensus services as a subset. Also competes with academic groups conducting Delphi studies. Differentiation is based on specialized focus, publication track record, and integrated campaign services.